Development of a diphtheria toxin based antiporcine CD3 recombinant immunotoxin.
about
Miniature Swine as a Clinically Relevant Model of Graft-Versus-Host DiseaseEffects of mobilization regimens in donors on outcomes of hematopoietic cell transplantation in miniature Swine.Recipient-matching of Passenger Leukocytes Prolongs Survival of Donor Lung Allografts in Miniature Swine.Enhanced de novo alloantibody and antibody-mediated injury in rhesus macaques.Lack of antidonor alloantibody does not indicate lack of immune sensitization: studies of graft loss in a haploidentical hematopoietic cell transplantation swine modelExpression and characterization of recombinant soluble porcine CD3 ectodomain molecules: mapping the epitope of an anti-porcine CD3 monoclonal antibody 898H2-6-15A truncated diphtheria toxin based recombinant porcine CTLA-4 fusion toxin.Lymphodepletional strategies in transplantation.Vascularized composite allograft tolerance across MHC barriers in a large animal model.Diphtheria-toxin based anti-human CCR4 immunotoxin for targeting human CCR4(+) cells in vivo.α-sarcin and RNase T1 based immunoconjugates: the role of intracellular trafficking in cytotoxic efficiency.Development of a diphtheria toxin-based recombinant porcine IL-2 fusion toxin for depleting porcine CD25+ cells.Diphtheria toxin-based anti-human CD19 immunotoxin for targeting human CD19+ tumorsEfficient production of single-chain fragment variable-based N-terminal trimerbodies in Pichia pastoris.Recombinant anti-monkey CD3 immunotoxin depletes peripheral lymph node T lymphocytes more effectively than rabbit anti-thymocyte globulin in naïve baboons.Edema and tetraparesis in a miniature pig after allogeneic hematopoietic cell transplantation.Diphtheria toxin-based bivalent human IL-2 fusion toxin with improved efficacy for targeting human CD25(+) cells.Porcine Treg depletion with a novel diphtheria toxin-based anti-human CCR4 immunotoxin.Improved Protein Toxin Delivery Based on ATTEMPTS Systems.
P2860
Q26782509-166C76D0-8FC1-4CD5-BF4D-7D5965BB61C4Q33406906-33B50D7D-35A2-4DDF-A767-1D7498898BC3Q35828393-EC8EE62E-B2F7-49C1-8D8A-BFC52564F643Q36575860-73574EC8-CF01-426A-B437-5CEECEA4760DQ36617576-188F5CD2-DB14-443F-80CA-D45252E3B1F6Q36811021-2602CD00-7623-438B-AC59-67F86F6E7B61Q36943986-DCEA4DDE-0A44-4113-B55A-952A7A29822AQ38118743-FD54CEE9-255A-47D2-ABF7-F0E756DF930FQ38577592-B73EFBD8-4B0D-4029-9F65-280AB493572BQ38877137-934D579D-770F-449B-BD83-929A10FCF69AQ38932236-870B6B1C-D678-4371-8665-9CB609F37F68Q39093557-2B223DE4-BFF9-491C-97B4-F78E50DAE370Q41127909-91E408BC-889B-4F2D-ACB7-B2E612D3F073Q41896587-14C993BC-4742-475E-ACFD-99EFC35F500EQ41985264-877E8B7D-86EA-4B36-91D7-C55300A47ED6Q42115220-362828D7-F8C7-4E8C-BD97-D0CFC07EB40FQ42765660-EEABAD1A-3E0B-4988-8B17-B02C271E4812Q45225428-A2C7E368-9681-4BDB-996B-2F6377763C4FQ46409297-DFE25C51-73AE-44BA-89CA-69E05D5651FE
P2860
Development of a diphtheria toxin based antiporcine CD3 recombinant immunotoxin.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Development of a diphtheria toxin based antiporcine CD3 recombinant immunotoxin.
@ast
Development of a diphtheria toxin based antiporcine CD3 recombinant immunotoxin.
@en
type
label
Development of a diphtheria toxin based antiporcine CD3 recombinant immunotoxin.
@ast
Development of a diphtheria toxin based antiporcine CD3 recombinant immunotoxin.
@en
prefLabel
Development of a diphtheria toxin based antiporcine CD3 recombinant immunotoxin.
@ast
Development of a diphtheria toxin based antiporcine CD3 recombinant immunotoxin.
@en
P2093
P2860
P356
P1476
Development of a diphtheria toxin based antiporcine CD3 recombinant immunotoxin.
@en
P2093
Abraham Matar
Christene A Huang
David H Sachs
David M Neville
Isabel Hanekamp
Raimon Duran-Struuck
Rebecca Crepeau
Srimathi Srinivasan
Zhirui Wang
P2860
P304
P356
10.1021/BC200230H
P577
2011-09-09T00:00:00Z